mRNA Flu Vaccine Study

Now Enrolling in Lincoln and Savannah

Now Enrolling

About this research study

Influenza (flu) is an infectious disease characterized by the abrupt onset of respiratory and systemic symptoms, such as fever, cough, sore throat, and congestion. Velocity is conducting a research study on an investigational mRNA Pandemic Influenza (global flu) vaccine for healthy adults age 18+.

Research studies are crucial, especially for evaluating investigational vaccines to see if they can protect children, seniors, and people with underlying medical conditions.

Eligible participants...

  • Must be age 65 or older, and in good health
  • BMI between 18 kg/m2 – 39 kg/m2, inclusive.
  • Will receive compensation for study-related time.
  • Do not need insurance to join this study.

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Lincoln, Nebraska • Velocity Clinical Research

4600 Valley Rd., Lincoln, NE 68510
Phone: (531) 530-2800

Savannah, Georgia • Velocity Clinical Research

340 Eisenhower Drive, #1500, Savannah, GA 31406
Phone: (912) 443-4253
Row concave Shape Decorative svg added to top

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy